Literature DB >> 1661197

Pathobiology of chronic hepatitis virus infection and hepatocellular carcinoma (HCC).

F Oliveri1, M R Brunetto, G C Actis, F Bonino.   

Abstract

Hepatitis viruses may cause liver cancer (HCC) through an indirect mechanism inducing inflammation and cirrhosis. Only hepatitis B virus (HBV) was shown to have a direct oncogenetic potential. Hepatitis D virus (HDV) infection, superimposed on the oncogenetic background provided by chronic HBV infection, appears to provide an additional risk for HCC. Patients with florid infections from both HBV and HDV and active liver inflammation develop HCC at a significantly younger age than those infected by HBV alone or infected by hepatitis C virus (about 10 years earlier). In patients positive for serum HBV-DNA/HDV-RNA and/or IgM anti-HBc/IgM anti-HD it is mandatory to program a more frequent (thrice a year) schedule of screenings (ultrasound scan, alpha-1-phetoprotein, etc.) for prophylaxis of HCC.

Entities:  

Mesh:

Year:  1991        PMID: 1661197

Source DB:  PubMed          Journal:  Ital J Gastroenterol        ISSN: 0392-0623


  4 in total

1.  Is high AgNOR quantity in hepatocytes associated with increased risk of hepatocellular carcinoma in chronic liver disease?

Authors:  M Derenzini; D Trerè; F Oliveri; E David; P Colombatto; F Bonino; M R Brunetto
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

2.  Overexpression of cyclooxygenase-2 in noncancerous liver tissue increases the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis.

Authors:  Yi-Fu He; Juan Jin; Wei Wei; Yan Chang; Bing Hu; Chu-Shu Ji; Wei-Dong Jia; Xiao-Qiu Wang; Ke Chen; Jian Chen
Journal:  Can J Gastroenterol       Date:  2010-07       Impact factor: 3.522

Review 3.  Hepatitis D and hepatocellular carcinoma.

Authors:  Zaigham Abbas; Minaam Abbas; Sarim Abbas; Lubna Shazi
Journal:  World J Hepatol       Date:  2015-04-18

4.  Hepatocellular carcinoma in hepatitis D: does it differ from hepatitis B monoinfection?

Authors:  Zaigham Abbas; Mustafa Qureshi; Saeed Hamid; Wasim Jafri
Journal:  Saudi J Gastroenterol       Date:  2012 Jan-Feb       Impact factor: 2.485

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.